Generic Sofosbuvir/Ledipasvir for Treatment of Naïve, Non-Cirrhotic, Easy to Treat Patients with Chronic Hepatitis C Genotype 4: 8 Vs. 12 Weeks of Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Generic Sofosbuvir/Ledipasvir for Treatment of Naïve, Non-Cirrhotic, Easy to Treat Patients with Chronic Hepatitis C Genotype 4: 8 Vs. 12 Weeks of Treatment

Published:2018-09-02 Issue:In Press Volume:In Press Page:
ISSN:1735-143X
Container-title:Hepatitis Monthly
language:
Short-container-title:Hepat Mon

Author:

Ibrahim Shousha Hend,Akl Karim,Ragheb Sherif,Medhat Eman,Esmat Gamal

Publisher

Briefland

Subject

Infectious Diseases,Hepatology

Reference30 articles.

1. The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment

2. The current and future disease burden of chronic hepatitis C virus infection in Egypt

3. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

4. Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Treatment of Ledipasvir/Sofosbuvir in Patients with Chronic Hepatitis C Virus: The Results of Five-year Follow-up;Viral Hepatitis Journal;2021-12-23

2. The Impact of Interferon-γ (IFN-γ) and IFN-γ-Inducible Protein 10 (IP-10) Genes’ Polymorphism on Risk of Hepatitis C Virus–Related Liver Cirrhosis;Immunological Investigations;2021-01-14

3. Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis;Bulletin of the World Health Organization;2019-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP